We, therefore, adopted a more robust approach where cancer cells with ephrinB2 knockout were implanted in the EFNB2fl/flTie2-Cre-ERT mice (herein referred to as the ephrinB2 double knockout group). The gene discussed is ELF3; the disease is cancer.